{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:41:10Z","timestamp":1784133670749,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC101-2320-B-002-026"],"award-info":[{"award-number":["NSC101-2320-B-002-026"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0774-8","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:12:45Z","timestamp":1518480765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study"],"prefix":"10.1186","volume":"18","author":[{"given":"Ching-Yu Julius","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ching","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-0175","authenticated-orcid":false,"given":"Po-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"774_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0002-9343(02)01021-5","volume":"112","author":"AA Mangoni","year":"2002","unstructured":"Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002;112:556\u201365.","journal-title":"Am J Med"},{"key":"774_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3945\/ajcn.110.004671","volume":"93","author":"KS Crider","year":"2011","unstructured":"Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, Maneval DR, Quinlivan EP, Li Z, Bailey LB, Berry RJ. MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011;93:1365\u201372.","journal-title":"Am J Clin Nutr"},{"key":"774_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1124\/pr.54.4.599","volume":"54","author":"A De Bree","year":"2002","unstructured":"De Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002;54:599\u2013618.","journal-title":"Pharmacol Rev"},{"key":"774_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"107","author":"GH Werstuck","year":"2001","unstructured":"Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263\u201373.","journal-title":"J Clin Invest"},{"key":"774_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202.","journal-title":"BMJ"},{"key":"774_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/003655100448473","volume":"60","author":"J Moller","year":"2000","unstructured":"Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest. 2000;60:491\u20139.","journal-title":"Scand J Clin Lab Invest"},{"key":"774_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0895-4356(02)00434-1","volume":"55","author":"LE Bautista","year":"2002","unstructured":"Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol. 2002;55:882\u20137.","journal-title":"J Clin Epidemiol"},{"key":"774_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrn727","volume":"3","author":"S Choe","year":"2002","unstructured":"Choe S. Potassium channel structures. Nat Rev Neurosci. 2002;3:115\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"774_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/oxfordjournals.aje.a008828","volume":"143","author":"P Verhoef","year":"1996","unstructured":"Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996;143:845\u201359.","journal-title":"Am J Epidemiol"},{"key":"774_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.arcmed.2014.08.003","volume":"45","author":"O Akyurek","year":"2014","unstructured":"Akyurek O, Akbal E, Gunes F. Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level. Arch Med Res. 2014;45:501\u20136.","journal-title":"Arch Med Res"},{"key":"774_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.CIR.102.11.1227","volume":"102","author":"JL Anderson","year":"2000","unstructured":"Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 2000;102:1227\u201332.","journal-title":"Circulation"},{"key":"774_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/01.CIR.102.6.605","volume":"102","author":"PJ Stubbs","year":"2000","unstructured":"Stubbs PJ, Al-Obaidi MK, Conroy RM, Collinson PO, Graham IM, Noble IM. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation. 2000;102:605\u201310.","journal-title":"Circulation"},{"key":"774_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"JF Toole","year":"2004","unstructured":"Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA. 2004;291:565\u201375.","journal-title":"JAMA"},{"key":"774_CR14","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","volume":"299","author":"CM Albert","year":"2008","unstructured":"Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027\u201336.","journal-title":"JAMA"},{"key":"774_CR15","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.2010.840","volume":"303","author":"JM Armitage","year":"2010","unstructured":"Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010;303:2486\u201394.","journal-title":"JAMA"},{"key":"774_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.300.7.795","volume":"300","author":"M Ebbing","year":"2008","unstructured":"Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygard O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300:795\u2013804.","journal-title":"JAMA"},{"key":"774_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0828-282X(06)70238-0","volume":"22","author":"E Lonn","year":"2006","unstructured":"Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the heart outcomes prevention evaluation (HOPE)-2 trial. Can J Cardiol. 2006;22:47\u201353.","journal-title":"Can J Cardiol"},{"key":"774_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijcard.2007.02.011","volume":"124","author":"SG Foussas","year":"2008","unstructured":"Foussas SG, Zairis MN, Makrygiannis SS, Manousakis SJ, Patsourakos NG, Adamopoulou EN, Beldekos DJ, Melidonis AI, Handanis SM, Manolis AJ, et al. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes. Int J Cardiol. 2008;124:312\u20138.","journal-title":"Int J Cardiol"},{"key":"774_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","volume":"63","author":"T Palmerini","year":"2014","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2014;63:299\u2013307.","journal-title":"J Am Coll Cardiol"},{"key":"774_CR20","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/eurheartj\/ehx437","volume":"38","author":"F D'Ascenzo","year":"2017","unstructured":"D'Ascenzo F, Iannaccone M, Saint-Hilary G, Bertaina M, Schulz-Schupke S, Wahn Lee C, Chieffo A, Helft G, Gili S, Barbero U, et al. Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients. Eur Heart J. 2017;38:3160\u201372.","journal-title":"Eur Heart J"},{"key":"774_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002490","volume":"4","author":"P Andell","year":"2015","unstructured":"Andell P, James SK, Cannon CP, Cyr DD, Himmelmann A, Husted S, Keltai M, Koul S, Santoso A, Steg PG, et al. Ticagrelor versus Clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease: an analysis from the platelet inhibition and patient outcomes (PLATO) trial. J Am Heart Assoc. 2015;4:e002490.","journal-title":"J Am Heart Assoc"},{"key":"774_CR22","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001\u201315.","journal-title":"N Engl J Med"},{"issue":"127","key":"774_CR23","first-page":"e362","volume":"2013","author":"PT O'Gara","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation. 2013;2013(127):e362\u2013425.","journal-title":"Circulation"},{"issue":"39","key":"774_CR24","first-page":"119","volume":"2018","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;2018(39):119\u201377.","journal-title":"Eur Heart J"},{"key":"774_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/cvr\/cvt062","volume":"99","author":"PY Chang","year":"2013","unstructured":"Chang PY, Chen YJ, Chang FH, Lu J, Huang WH, Yang TC, Lee YT, Chang SF, Lu SC, Chen CH. Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovasc Res. 2013;99:137\u201345.","journal-title":"Cardiovasc Res"},{"key":"774_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.108.171082","volume":"102","author":"PY Chang","year":"2008","unstructured":"Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH, Chang SF, Liao WS, Chen CH, Lee YT. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res. 2008;102:933\u201341.","journal-title":"Circ Res"},{"key":"774_CR27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/hc3101.092213","volume":"104","author":"PY Chang","year":"2001","unstructured":"Chang PY, Luo S, Jiang T, Lee YT, Lu SC, Henry PD, Chen CH. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. Circulation. 2001;104:588\u201393.","journal-title":"Circulation"},{"key":"774_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2459\/JCM.0000000000000551","volume":"18","author":"E Cerrato","year":"2017","unstructured":"Cerrato E, Barbero U, D'Ascenzo F, Taha S, Biondi-Zoccai G, Omede P, Bianco M, Echavarria-Pinto M, Escaned J, Gaita F, Varbella F. What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown). 2017;18:758\u201370.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"774_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.15537\/smj.2015.7.11453","volume":"36","author":"C Liu","year":"2015","unstructured":"Liu C, Yang Y, Peng D, Chen L, Luo J. Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease. Saudi Med J. 2015;36:839\u201346.","journal-title":"Saudi Med J"},{"key":"774_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12872-017-0475-8","volume":"17","author":"Y Ma","year":"2017","unstructured":"Ma Y, Peng D, Liu C, Huang C, Luo J. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases. BMC Cardiovasc Disord. 2017;17:37.","journal-title":"BMC Cardiovasc Disord"},{"key":"774_CR31","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.numecd.2010.10.020","volume":"22","author":"AO Akanji","year":"2012","unstructured":"Akanji AO, Thalib L, Al-Isa AN. Folate, vitamin B(1)(2) and total homocysteine levels in Arab adolescent subjects: reference ranges and potential determinants. Nutr Metab Cardiovasc Dis. 2012;22:900\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"774_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.numecd.2011.10.001","volume":"23","author":"B Zappacosta","year":"2013","unstructured":"Zappacosta B, Persichilli S, Iacoviello L, Di Castelnuovo A, Graziano M, Gervasoni J, Leoncini E, Cimino G, Mastroiacovo P. Folate, vitamin B12 and homocysteine status in an Italian blood donor population. Nutr Metab Cardiovasc Dis. 2013;23:473\u201380.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"774_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","volume":"340","author":"PF Jacques","year":"1999","unstructured":"Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:1449\u201354.","journal-title":"N Engl J Med"},{"key":"774_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/hc0102.101388","volume":"105","author":"SN Doshi","year":"2002","unstructured":"Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002;105:22\u20136.","journal-title":"Circulation"},{"key":"774_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1536\/jhj.44.201","volume":"44","author":"Y Takeda","year":"2003","unstructured":"Takeda Y, Suzuki S, Fukutomi T, Kondo H, Sugiura M, Suzumura H, Murasaki G, Okutani H, Itoh M. Elevated white blood cell count as a risk factor of coronary artery disease: inconsistency between forms of the disease. Jpn Heart J. 2003;44:201\u201311.","journal-title":"Jpn Heart J"},{"key":"774_CR36","first-page":"51","volume":"48","author":"ZN Hatmi","year":"2010","unstructured":"Hatmi ZN, Saeid AK, Broumand MA, Khoshkar SN, Danesh ZF. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study. Acta Med Iran. 2010;48:51\u20137.","journal-title":"Acta Med Iran"},{"key":"774_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4067\/S0034-98872010001200018","volume":"138","author":"SJL Cabrerizo Garc\u00eda","year":"2010","unstructured":"Cabrerizo Garc\u00eda SJL, Zalba EB, P\u00e9rez CJI, Ruiz RF. Leukocyte count as a risk factor for coronary adverse events among patients admitted for an acute coronary syndrome. Rev Med Chil. 2010;138:274\u201380.","journal-title":"Rev Med Chil"},{"key":"774_CR38","first-page":"3769152","volume":"2016","author":"U Barbero","year":"2016","unstructured":"Barbero U, D'Ascenzo F, Nijhoff F, Moretti C, Biondi-Zoccai G, Mennuni M, Capodanno D, Lococo M, Lipinski MJ, Gaita F. Assessing risk in patients with stable coronary disease: when should we intensify care and follow-up? Results from a meta-analysis of observational studies of the COURAGE and FAME era. Scientifica (Cairo). 2016;2016:3769152.","journal-title":"Scientifica (Cairo)"},{"key":"774_CR39","first-page":"69","volume":"103","author":"DR Ribeiro","year":"2014","unstructured":"Ribeiro DR, Ramos AM, Vieira PL, Menti E, Bordin OL Jr, Souza PA, Quadros AS, Portal VL. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 2014;103:69\u201375.","journal-title":"Arq Bras Cardiol"},{"key":"774_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-017-0304-3","volume":"10","author":"R Marfella","year":"2018","unstructured":"Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabro P, Mauro C, Pieretti G, Coppola A, et al. Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis. Diabetol Metab Syndr. 2018;10:1.","journal-title":"Diabetol Metab Syndr"},{"key":"774_CR41","doi-asserted-by":"publisher","unstructured":"Marfella R, Sardu C, Calabro P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, Barbieri M. Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: effects of incretin treatment. Diabetes Obes Metab. 2017. \n                    https:\/\/doi.org\/10.1111\/dom.13122\n                    \n                  . [Epub ahead of print].","DOI":"10.1111\/dom.13122"},{"key":"774_CR42","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1016\/j.ijcard.2013.06.053","volume":"168","author":"R Marfella","year":"2013","unstructured":"Marfella R, Rizzo MR, Siniscalchi M, Paolisso P, Barbieri M, Sardu C, Savinelli A, Angelico N, Del Gaudio S, Esposito N, et al. Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage. Int J Cardiol. 2013;168:3954\u201362.","journal-title":"Int J Cardiol"},{"key":"774_CR43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH05-01-0067","volume":"94","author":"A Undas","year":"2005","unstructured":"Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost. 2005;94:907\u201315.","journal-title":"Thromb Haemost"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:40:37Z","timestamp":1589848837000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0774-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0774-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"26 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board (National Taiwan University Hospital Research Ethics Committee) with approval number NTUH-REC No. 201112123RIC, and all participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"33"}}